Skip to main content

Advertisement

Log in

Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients

  • Clinical Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Pleural effusion samples were obtained from 55 patients with malignant disease, including patients with primary lung cancers and those with a variety of other tumours metastatic to the pleura. The effusions were assayed for the presence of hepatocyte growth factor/scatter factor (HGF/SF), by both ELISA and bioassay. The presence of malignant cells in the effusions was also assessed. Detectable amounts of the factor, as judged by both criteria, were found in over 90% of all the effusions, including those from patients with a wide variety of carcinomas and also lymphomas. A wide range of HGF/SF levels were found for all tumour classes, some effusions containing high levels above 4 ng ml-1. It is concluded that tumours within the pleura and adjacent lung tissue are usually exposed to biologically significant levels of HGF/SF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eagles, G., Warn, A., Ball, R. et al. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer 73, 377–381 (1996). https://doi.org/10.1038/bjc.1996.64

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.64

  • Springer Nature Limited

This article is cited by

Navigation